We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
AUM
$2.84B
AUM Growth
+$291M
Cap. Flow
+$191M
Cap. Flow %
6.72%
Top 10 Hldgs %
31.1%
Holding
193
New
73
Increased
29
Reduced
31
Closed
51

Sector Composition

Rank Sector Weight
1 Communication Services 21.19%
2 Technology 16.04%
3 Healthcare 13.29%
4 Consumer Discretionary 12.44%
5 Energy 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$140B
$31.2M 1.1%
1,018,832
+486,352
+91% +$15.3M
YELP icon
27
Yelp
YELP
$1.38B
$29.7M 1.05%
+1,031,227
New +$27.1M
ARMH
28
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$29.4M 1.03%
649,264
-164,541
-20% -$7.77M
CVX icon
29
Chevron
CVX
$388B
$28.5M 1%
+316,397
New +$28.5M
GSK icon
30
CALL
GSK
GSK
$103B
$28.2M 0.99%
560,000
+80,000
+17% +$4.08M
SWK icon
31
Stanley Black & Decker
SWK
$14.2B
$27.8M 0.98%
+260,102
New +$27.4M
TJX icon
32
TJX Companies
TJX
$170B
$26.7M 0.94%
+753,122
New +$26.8M
APA icon
33
APA Corp
APA
$12.8B
$26.5M 0.93%
+595,389
New +$27.7M
HAL icon
34
Halliburton
HAL
$27.9B
$26.3M 0.93%
773,691
+671,258
+655% +$25.3M
KO icon
35
Coca-Cola
KO
$354B
$25.9M 0.91%
+602,995
New +$25.6M
VRSN icon
36
VeriSign
VRSN
$25.5B
$25.6M 0.9%
292,844
-192,119
-40% -$16M
BMY icon
37
Bristol-Myers Squibb
BMY
$127B
$24.3M 0.86%
+353,360
New +$23.4M
TEVA icon
38
Teva Pharmaceuticals
TEVA
$35.9B
$23.5M 0.83%
+357,991
New +$22.1M
BIIB icon
39
CALL
Biogen
BIIB
$29.9B
$23M 0.81%
75,000
PRGO icon
40
Perrigo
PRGO
$1.4B
$22.5M 0.79%
+155,722
New +$23.9M
STJ
41
DELISTED
St Jude Medical
STJ
$22.5M 0.79%
+364,560
New +$23M
HUM icon
42
Humana
HUM
$46.7B
$22.5M 0.79%
126,029
+31,677
+34% +$5.56M
ORLY icon
43
O'Reilly Automotive
ORLY
$72.4B
$22.4M 0.79%
+1,328,715
New +$23M
GDDY icon
44
GoDaddy
GDDY
$12.3B
$22.4M 0.79%
700,000
-450,000
-39% -$13.7M
AMGN icon
45
Amgen
AMGN
$203B
$22.2M 0.78%
+136,497
New +$21.5M
NBL
46
DELISTED
Noble Energy, Inc.
NBL
$20.5M 0.72%
+621,731
New +$21.7M
MDLZ icon
47
Mondelez International
MDLZ
$77.7B
$20.4M 0.72%
453,952
+152,151
+50% +$6.81M
MJN
48
CALL
DELISTED
Mead Johnson Nutrition Company
MJN
$19.7M 0.69%
250,000
-25,000
-9% -$1.97M
OMF icon
49
OneMain Financial
OMF
$6.9B
$19.5M 0.69%
470,049
+166,430
+55% +$7.64M
MNK
50
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$18.7M 0.66%
250,628
+6,136
+3% +$413K

Similar funds

Ascend Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Ascend Capital held 193 positions worth $2.84B, up 11% from $2.55B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ascend Capital deployed $191M of net new capital in Q4 2015, opening 73 new positions and adding to 29 existing holdings. Its largest new stake was Ashland: 1,801,800 shares worth $90.5M.

By sector, the portfolio is most concentrated in Communication Services at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Golar LNG, an estimated $64.6M trimmed.

  • Ascend Capital's largest Q4 2015 buy was Ashland: 1,801,800 shares worth $90.5M.
  • Ascend Capital added most to Liberty Global Class A in Q4 2015, an estimated $50.6M increase.
  • Ascend Capital's biggest Q4 2015 reduction was Golar LNG, cutting an estimated $64.6M.
  • Ascend Capital fully exited Alphabet (Google) Class C in Q4 2015, selling an estimated $110M.
  • Ascend Capital's ten largest holdings make up 31% of its $2.84B portfolio in Q4 2015.
  • Ascend Capital opened 73 new positions and closed 51 in Q4 2015.
  • Ascend Capital's portfolio value rose 11% quarter-over-quarter to $2.84B.

Based on Ascend Capital's 13F filing for Q4 2015, filed 12 Feb 2016.